2 deals
Perth infection management medtech Cytophenix prescribed $1.3 million in pre-Seed
Perth medtech spin-out Cytophenix raised a pre-seed round above its target to advance trials and grow the team behind FloCAST, a rapid test identifying effective antibiotics, after earlier grants and accelerator programs.